Spindletop Health Acquisition Corp.

Status: Liquidated
U=S+W/2 W=S@11.5
IPO Proceeds, $M $230.00M
IPO Date Nov 4, 2021
CEO Evan S. Melrose, M.D., MBA
Left Lead Barclays
IPO Cash in Trust 102.0%
SPAC Tenor 15 + (3) or 15 + (2*3)
IPO Sector Healthcare

Healthcare services, healthcare information technology, insurance and related products, biotechnology, pharmaceuticals, medical devices, and diagnostics

IPO Geography Global
Target Company N/A
Deal Announced N/A
Deal Size, $M TBD
Deal Sector TBD
Deal Geography TBD
SEC Filings www.sec.gov
Approval Vote TBD
Amendment Vote Dec 20, 2022
Closing Date Dec 20, 2022
SHCA SHCAU SHCAW

Sign up for Free Trial

No credit card required

Sign in for more on Spindletop Health Acquisition Corp.:

  • Structure and cap table
  • 8 directors & officers
  • 12 filings and events
  • 2 underwriters
Structure

Sign in to view structure, cap table, and calendar of events.

Team
Name Age Title
Evan S. Melrose, M.D., MBA 51 Chief Executive Officer, Chief Financial Officer and Director
James H. Henry, CPA 63 Chairman of the Board of Directors
Steve Whitlock, MBA 59 Secretary
JD Moore, MBA 48 Senior Vice President, Corporate Development
Kelly Huang, Ph.D. 52 Chief Operating Officer
Craig Cordola, MBA 49 Director
Todd Fruchterman, M.D., Ph.D. 51 Director
David Nash, M.D., MBA 65 Director

Sign in to view team biographies and more sponsor and affiliate data.

Advisors
Underwriters
Barclays Joint BR 13,000,000 units
Stifel Nicolaus Joint BR 7,000,000
20,000,000 units
Up-Front UW fee 2.00 %
Deferred UW fee 3.50 %

Sign in to view more advisor data.

Filings

Sign in to view 12 filings.

Shareholders

Sign in to view shareholders 13F filing data.